Ithaka Group analyzes Q3 market gains driven by AI capex, warns of valuation risks, and shares portfolio insights. Explore ...

Explore a potential trade with CytomX (CTMX) stock as Q1’26 clinical data approaches for its EpCAM-targeting therapy. Read ...

Arq recently completed commissioning of its much-touted granular activated carbon expansion project. See why we are neutral on ARQ stock.

The dollar has bounced back some since the beginning of July with the WSJ Dollar Index rising today to 96.4, up by 2.6% from ...

CRISPR Therapeutics’ stock is surging as in-vivo therapies show promise. Learn about CRSP stock's risks, long-term upside, ...

Altria has stable profits, strong cash flow, new partnerships, and a 6.23% yield. Read here for an anaysis of MO stock and ...

With global money supply continuing to expand and confidence in fiat systems wavering, Bitcoin is emerging as a credible hard ...

CoreWeave is evolving from an AI cloud hardware provider to a full-stack agentic infrastructure platform. Read why CRWV stock ...

All nine indexes on our world markets watch list have posted gains through October 13, 2025. Hong Kong's Hang Seng is in the ...

Bilibili remains a capital-light, platform-based business with significant profitability potential amid advertising and ...

Warden Capital warns of an AI-driven market mania, outlines defensive positioning, and flags quantum stocks as shorts. Read ...

Target may be primed for a rebound as strategic shifts and solid financials set the stage for future growth. See here for ...